SCHEMBL10656803

SCHEMBL10656803

CC1=C(C(=O)O)C(c2cccc([N+](=O)[O-])c2)C(C(=O)O)=C(C)N1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1F O60840 7/20 0.53
CACNA1D Q01668 7/20 0.53
CACNA1S Q13698 7/20 0.53
CACNA1C Q13936 7/20 0.53
ADORA3 P0DMS8 1/20 0.53
PDE1C Q14123 1/20 0.51
ATM Q13315 1/20 0.51
CACNA1B Q00975 1/20 0.50
CYP1A2 P05177 3/20 0.49
CYP3A4 P08684 3/20 0.49
CYP2C9 P11712 3/20 0.49
CYP2C19 P33261 3/20 0.49
MAPT P10636 3/20 0.49
CYP2D6 P10635 2/20 0.49
TSHR P16473 2/20 0.49
NFKB1 P19838 2/20 0.49
LMNA P02545 2/20 0.49
GMNN O75496 1/20 0.49
BLM P54132 1/20 0.49
PMP22 Q01453 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11681591 0.92 MAPT (0.61) CACNA1FCACNA1DCACNA1SCACNA1CADORA3
SCHEMBL31191654 0.92 MAPT (0.61) CACNA1FCACNA1DCACNA1SCACNA1CADORA3
SCHEMBL3443991 0.90 CACNA1F (0.67) CACNA1FCACNA1DCACNA1SCACNA1CADORA3
SCHEMBL3443984 0.90 CACNA1F (0.67) CACNA1FCACNA1DCACNA1SCACNA1CADORA3
SCHEMBL14977478 0.88 MAPT (0.49) CACNA1FCACNA1DCACNA1SCACNA1CADORA3
SCHEMBL14977476 0.88 MAPT (0.49) CACNA1FCACNA1DCACNA1SCACNA1CADORA3
SCHEMBL3443986 0.86 CYP1A2 (0.55) CACNA1FCACNA1DCACNA1SCACNA1CADORA3
SCHEMBL16189736 0.86 TSHR (0.66) CACNA1FCACNA1DCACNA1SCACNA1CADORA3
SCHEMBL30873727 0.86 CYP1A2 (0.57) CACNA1FCACNA1DCACNA1SCACNA1CADORA3
SCHEMBL7482293 0.85 CACNA1F (0.46) CACNA1FCACNA1DCACNA1SCACNA1CADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118206480-A Purification method of 1, 4-dihydro-2, 6-dimethyl-4- (3-nitrophenyl) pyridine-3, 5-dicarboxylic acid monomethyl ester 河北一品生物医药有限公司 2024-06-18 CN claimed
CN-118930479-A Preparation method of benidipine hydrochloride 重庆煜洋药业有限公司 2024-11-12 CN disclosed
CN-118930479-A Preparation method of benidipine hydrochloride 重庆煜洋药业有限公司 2024-11-12 CN disclosed
CN-118206480-A Purification method of 1, 4-dihydro-2, 6-dimethyl-4- (3-nitrophenyl) pyridine-3, 5-dicarboxylic acid monomethyl ester 河北一品生物医药有限公司 2024-06-18 CN disclosed
CN-115322118-B Preparation method of benidipine hydrochloride intermediate 重庆华邦制药有限公司 2024-04-30 CN disclosed
CN-1015460-B Process for preparing derivatives of asymmetric esters of 1, 4-dihydropyridine-3, 5-dicarboxylic acid SORI SOC RECH IND (FR) 1992-02-12 CN disclosed
EP-0245680-A3 A PROCESS FOR THE PREPARATION OF 2-(N-BENZYL-N-METHYLAMINO)-ETHYL-METHYL-1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-3,5-PYRIDINE DICARBOXYLATE HYDROCHLORIDE ISTITUTO LUSO FARMACO D'ITALIA S.p.A. (IT) 1988-04-20 EP disclosed
EP-0245680-A2 A process for the preparation of 2-(N-benzyl-N-methylamino)-ethyl-methyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine dicarboxylate hydrochloride ISTITUTO LUSO FARMACO D'ITALIA S.p.A. (IT) 1987-11-19 EP disclosed
CN-87102452-A 1, the derivative of the asymmetric ester of 4-dihydropyridine-3,5-dicarboxylic acid 1987-10-14 CN disclosed